Sehrish Ashraf | Molecular Biology | Innovative Research Award

Published on by Molecular Biologist

 

Innovative Research Award

Sehrish Ashraf

Emerson University Multan, Pakistan

Sehrish Ashraf
Affiliation Emerson University Multan
Country Pakistan
Google Scholar ID rcsbaYAAAAJ
Documents 10
Citations 120
h-index 6
Subject area Molecular Biology
Event International Molecular Biologist Awards
ORCID 0009-0006-9527-6617
Scopus 57202251393

Sehrish Ashraf is a researcher affiliated with Emerson University Multan, Pakistan, whose stated subject area is molecular biology. This academic recognition profile presents the available researcher identifiers, reported bibliometric indicators, and the context of the Innovative Research Award associated with the International Molecular Biologist Awards. Bibliometric values are included as supplied profile data and should be interpreted in relation to their source and retrieval date. [1] [2].

Abstract

Sehrish Ashraf, affiliated with Emerson University Multan in Pakistan, and identifies molecular biology as the stated subject area. [1] [2] The profile also lists an ORCID identifier and a Scopus author record, which can help readers distinguish the researcher’s records and locate associated scholarly outputs. [3] The Innovative Research Award is presented here in the context of the International Molecular Biologist Awards. The available information does not independently establish the award’s assessment outcome, the specific works evaluated, or the methodology used for selection. [4]

Keywords

Sehrish Ashraf; molecular biology; academic research; scholarly publications; research metrics; citation analysis; ORCID; Scopus; Google Scholar; Innovative Research Award; Pakistan; International Molecular Biologist Awards.

Introduction

Molecular biology examines biological processes at the molecular level, including the structure and function of nucleic acids, proteins, and their interactions within cells. Research in this field supports investigations into cellular mechanisms, gene regulation, molecular interactions, and biological systems. Individual researcher profiles can help readers locate scholarly records and understand the broad academic context of a researcher’s work.

Sehrish Ashraf is identified in the supplied information as being affiliated with Emerson University Multan, Pakistan. Molecular biology is listed as the relevant subject area. The identifiers supplied for the researcher include an ORCID profile, a Scopus author profile, and a Google Scholar profile. These services provide different mechanisms for identifying researchers and retrieving publication-related information. [1] [2] [3]

Research Profile

The supplied academic details associate Sehrish Ashraf with Emerson University Multan and the discipline of molecular biology. The following summary reproduces the identifiers and bibliometric figures provided for this profile. The figures have not been independently audited for this article, and a retrieval date was not supplied.

ORCID provides persistent researcher identifiers intended to distinguish individuals and connect their scholarly activities. Scopus author records organize publications and related metrics indexed by Scopus, while Google Scholar profiles present scholarly records and citation information drawn from Google Scholar’s indexing system. Differences in coverage and record matching mean that figures from these services should not automatically be treated as interchangeable. [1] [2] [3]

Research Contributions

The supplied information identifies molecular biology as the researcher’s subject area but does not include a verified publication list, article titles, abstracts, experimental methods, or descriptions of individual findings. Consequently, specific discoveries, techniques, or scientific advances cannot be attributed to Sehrish Ashraf from the available data alone. A detailed assessment of research contributions would require examination of the researcher’s publications and their documented findings.

A publication-based review may examine the following dimensions where reliable evidence is available:

  • The scientific questions addressed and their relevance to molecular biology.
  • The research methods, experimental design, analytical approaches, and reproducibility of reported findings.

Publications

The supplied profile reports 10 documents. However, individual publication metadata, including titles, journal names, publication years, author order, and digital object identifiers (DOIs), were not provided as part of the input data. The figure should therefore be treated as a reported profile statistic rather than a verified bibliography. Readers can consult the researcher’s linked Scopus and Google Scholar records for publication details and any available citation information. [1] [2]

For a complete publication record, each entry should be checked against the publisher’s version of record. Where available, a DOI should be included as a persistent link to the corresponding publication.

Research Impact

The supplied bibliometric information reports 120 citations and an h-index of 6. The h-index is a bibliometric indicator that combines publication output and citation counts: a researcher has an h-index of at least h when h publications have each received at least h citations. Citation counts and h-index values are dependent on database coverage, author-name disambiguation, document types, and the date on which records are retrieved. [2] [5]

The reported figures provide one quantitative view of the available research profile. A fuller assessment would consider the content and reliability of individual publications, the contribution of the researcher to collaborative work, the context in which citations occur, and evidence of influence on further research or practical applications.

Award Suitability

The title associated with this article is the Innovative Research Award, presented in the context of the International Molecular Biologist Awards. The supplied information establishes the intended recognition category and identifies the researcher’s institution, subject area, and reported bibliometric indicators. It does not provide an official award decision, selection notice, judging rubric, or evidence documenting the specific research achievements assessed by the organizers.

A transparent assessment of suitability for an innovative research award would ordinarily consider evidence such as:

  1. Originality of the research question, approach, or resulting knowledge.
  2. Methodological rigor and the reproducibility of reported findings.
  3. Documented contribution to the relevant field and distinction from prior work.

Conclusion

Sehrish Ashraf is identified in the supplied profile as a researcher affiliated with Emerson University Multan, Pakistan, with molecular biology listed as the subject area.  A comprehensive account of scientific contributions and research impact would require verification of individual publications, their findings, and the researcher’s documented role in the work. The Innovative Research Award designation is included as the stated recognition context, while confirmation of a formal award outcome should be based on verifiable organizer documentation.

References

  1. Elsevier. (n.d.). Scopus author details: Sehrish Ashraf, Author ID 57202251393. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57202251393
  2. Google. (n.d.). Google Scholar profile: Sehrish Ashraf, user ID 0rcsbaYAAAAJ.
    https://scholar.google.com.tr/citations?user=0rcsbaYAAAAJ&hl=lv
  3. ORCID. (n.d.). ORCID record: Sehrish Ashraf, ORCID iD 0009-0006-9527-6617.
    https://orcid.org/0009-0006-9527-6617
  4. International Molecular Biologist Awards. (n.d.). Official award website.
    https://molecularbiologist.org/
  5. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102

Promy Virk | Molecular Biology | Innovative Molecular Biologist Award

Published on by Molecular Biologist

Innovative Molecular Biologist Award

Promy Virk
King Saud University, Saudi Arabia

Promy Virk
Affiliation King Saud University
Country Saudi Arabia
Google Scholar ID clmjNO4AAAAJ
Citations 1,788
h-index 30
i10 index 22
Subject Area Molecular Biology
Event International Molecular Biologist Awards
ORCID 0000-0002-4030-7651
Scopus 55131550000

Promy Virk is a molecular biology researcher affiliated with King Saud University in Saudi Arabia. The researcher’s academic profile is associated with molecular biology and can be identified through persistent researcher identifiers and scholarly indexing services, including ORCID, Scopus, and Google Scholar. The available scholarly profile information records 1,788 citations, an h-index of 30, and an i10 index of 22 at the time of compilation. [1] [2] [3]

Abstract

Promy Virk, a researcher affiliated with King Saud University, Saudi Arabia, whose stated subject area is molecular biology. The profile consolidates researcher-identification information, bibliometric indicators, institutional affiliation, and award context into a structured academic format. According to the supplied scholarly profile information, the researcher has a Google Scholar h-index of 30, an i10 index of 22, and 1,788 citations. [1] [2] The recognition discussed on this page is connected with the International Molecular Biologist Awards.

Keywords

  • Promy Virk
  • Molecular Biology
  • King Saud University
  • Saudi Arabia

Introduction

Molecular biology examines biological processes at the molecular level, including the organization, expression, regulation, and interaction of biological macromolecules. Contemporary molecular biology relies on integrated experimental and computational approaches to investigate biological systems and to translate molecular observations into reproducible scientific knowledge. Standard molecular biology methodologies have contributed substantially to the characterization and quantification of biological processes across diverse research settings. [5]

Within this broad discipline, researcher identification and scholarly attribution are increasingly supported by persistent identifiers and bibliographic databases. ORCID provides a persistent digital identifier intended to distinguish researchers and connect them with their scholarly contributions, while Scopus and Google Scholar provide mechanisms for discovering and evaluating indexed scholarly output. [2] [1] [3]

Research Profile

Promy Virk is identified in the supplied academic information as a molecular biology researcher affiliated with King Saud University in Saudi Arabia. The research profile includes a Google Scholar identifier, ORCID identifier, and Scopus author identifier, enabling the researcher to be distinguished across several scholarly information systems. [1] [2] [3]

The bibliometric indicators supplied for this profile include 1,788 citations, an h-index of 30, and an i10 index of 22. Such indicators are commonly used as quantitative descriptors of scholarly visibility and citation activity, although they should be interpreted in relation to disciplinary practices, publication history, database coverage, authorship patterns, and the date on which the metrics are observed. [3]

Research Contributions

The available profile information places Promy Virk within the field of molecular biology. A researcher operating in this field may contribute through experimental investigation, molecular characterization, biological mechanism studies, methodological development, collaborative research, and dissemination of findings through peer-reviewed scholarly publications. The specific contribution of an individual researcher is best assessed through the primary literature, author-level publication records, and independently verifiable institutional information.

The presence of a persistent ORCID identifier provides a mechanism for connecting scholarly works with the researcher and reducing ambiguity arising from variations in author names. [2] The associated Scopus author profile provides an additional bibliographic record through which publication and citation information may be examined. [1]

  • Research activity within the broad discipline of molecular biology.
  • Scholarly visibility represented through indexed citation metrics.
  • Persistent researcher identification through ORCID, Scopus, and Google Scholar.

Publications

Publication records are an important component of evaluating research activity because they provide the primary scholarly record of scientific findings. For Promy Virk, publication information can be explored through the researcher’s Scopus author record and Google Scholar profile. [1] [3] These databases may differ in their coverage, author disambiguation procedures, citation calculations, and update schedules; therefore, bibliometric values should be considered database-specific rather than universal measures of research performance.

Persistent identifiers and indexed author profiles are particularly useful when assessing publication records over time because they can assist in distinguishing authors with similar or identical names. ORCID provides an identifier designed for this purpose, while bibliographic services provide complementary publication and citation information. [2]

Research Impact

The supplied Google Scholar metrics indicate 1,788 citations, an h-index of 30, and an i10 index of 22. [3] These values provide quantitative information about the citation history represented in the corresponding Google Scholar profile. Citation indicators can assist in describing scholarly reach, but they do not independently establish the quality, originality, societal value, or practical significance of individual research contributions.

Research impact in molecular biology can be considered through multiple dimensions, including influence on subsequent scientific studies, methodological adoption, collaboration, education, translational relevance, and contribution to understanding biological mechanisms. A balanced assessment therefore combines bibliometric indicators with examination of publications, research context, peer recognition, and independently verifiable evidence.

Award Suitability

The supplied academic profile identifies Promy Virk with a molecular biology research background, an affiliation with King Saud University, and measurable scholarly activity represented by citation and author-index indicators. These characteristics provide a factual basis for considering the researcher within an academic recognition framework focused on molecular biology. [1] [3]

The Innovative Molecular Biologist Award is presented here in the context of the International Molecular Biologist Awards. Award suitability should ultimately be determined according to the event’s published eligibility criteria, nomination procedures, review process, and independently verifiable evidence of research contributions. The official award website provides the appropriate source for current event information and requirements. [4]

Conclusion

Promy Virk is an academic researcher affiliated with King Saud University in Saudi Arabia and identified within the subject area of molecular biology. The supplied scholarly indicators record 1,788 citations, an h-index of 30, and an i10 index of 22, while ORCID, Scopus, and Google Scholar identifiers provide complementary mechanisms for researcher identification and scholarly discovery. [1] [2] [3]

The profile provides a structured academic basis for recognition under the Innovative Molecular Biologist Award category associated with the International Molecular Biologist Awards. Assessment of research excellence should remain grounded in the primary scholarly record, institutional information, transparent award criteria, and appropriately contextualized bibliometric evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Promy Virk, Author ID 55131550000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55131550000
  2. ORCID. (n.d.). ORCID record: Promy Virk. ORCID.
    https://orcid.org/0000-0002-4030-7651
  3. Google Scholar. (n.d.). Google Scholar profile: Promy Virk. Google Scholar.
    https://scholar.google.com/citations?user=clmjNO4AAAAJ&hl=en&authuser=1
  4. International Molecular Biologist Awards. (n.d.). International Molecular Biologist Awards — Official Website.
    https://molecularbiologist.org/
  5. Bustin, S. A., et al. (2009). The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry.
    https://doi.org/10.1373/clinchem.2008.112797

Tebelay Dilnessa | Microbiology | Innovative Molecular Biologist Award

Published on by Molecular Biologist

Innovative Molecular Biologist Award

Tebelay Dilnessa
Debre Markos University, Ethiopia

Tebelay Dilnessa
Affiliation Debre Markos University
Country Ethiopia
Google Scholar ID a5xs_XsAAAAJ
Citations 1,174
h-index 16
i10 index 22
Subject Area Microbiology
Event International Molecular Biologist Awards
ORCID 0000-0002-3713-6783
Scopus 57190571702

Tebelay Dilnessa is a microbiology researcher affiliated with Debre Markos University in Ethiopia. His documented research activity encompasses medical microbiology, infectious diseases, antimicrobial resistance, tuberculosis, bacterial infections, diagnostic microbiology, and related public-health questions. His scholarly record includes collaborative research addressing clinically relevant microorganisms and laboratory-based investigation of infectious diseases. [1] [5]

Abstract

Tebelay Dilnessa is a microbiology researcher whose scholarly work is associated with medical laboratory science, infectious diseases, antimicrobial resistance, tuberculosis, bacterial pathogens, and diagnostic microbiology. His publication record includes studies of antimicrobial susceptibility, infectious disease epidemiology, laboratory diagnosis, and systematic evidence synthesis. Available scholarly records identify Debre Markos University among his institutional affiliations and document his contribution to collaborative research in microbiology and related biomedical disciplines. [1] [4]

Keywords

Microbiology; medical microbiology; antimicrobial resistance; infectious diseases; tuberculosis; bacterial pathogens; antimicrobial susceptibility; diagnostic microbiology; public health; molecular microbiology.

Introduction

Microbiology integrates the study of microorganisms with laboratory methods used to understand infectious diseases, antimicrobial susceptibility, pathogen transmission, and diagnostic challenges. Within this broad field, research on bacterial resistance and infectious disease surveillance has particular relevance to clinical laboratory practice and public health.

Dilnessa’s published work reflects this applied microbiological orientation. His research has included investigations of bacterial pathogens, antimicrobial resistance patterns, tuberculosis, viral infection diagnosis, intestinal parasites, and other infectious disease questions. A number of these studies were conducted in collaboration with researchers and clinical institutions in Ethiopia, providing evidence from local healthcare settings. [2] [3]

Research Profile

Dilnessa’s research profile is centered on microbiology and medical laboratory science, with recurring themes involving infectious agents, antimicrobial susceptibility, epidemiology, and laboratory-based characterization of pathogens. His work spans both primary research and evidence synthesis, allowing his publication record to address individual clinical settings as well as broader patterns reported across multiple studies.

  • Medical and clinical microbiology, including investigation of bacterial pathogens and laboratory findings.
  • Antimicrobial resistance and susceptibility testing, particularly involving clinically important bacterial species.
  • Tuberculosis and other infectious diseases affecting public health in Ethiopia.

The combination of these areas places his work within an applied research framework connecting microbiological investigation with clinical laboratory practice and public-health research. [1] [5]

Research Contributions

One notable area of Dilnessa’s research concerns antimicrobial resistance. His publications have examined antimicrobial susceptibility patterns and resistance among bacterial isolates, contributing data relevant to the interpretation of resistance in clinical and healthcare environments. Such studies are important because laboratory susceptibility information can support epidemiological understanding and inform approaches to antimicrobial stewardship.

His work also includes research on tuberculosis and associated infections. Research involving tuberculosis patients and co-infections contributes to the broader evidence base concerning disease burden, risk factors, treatment challenges, and laboratory surveillance in resource-constrained healthcare settings. [4]

Dilnessa has additionally contributed to research concerning diagnostic approaches to viral infections, intestinal parasites, ocular infections, and other microbiological conditions. These studies demonstrate the breadth of his work across laboratory diagnosis, pathogen identification, epidemiology, and antimicrobial susceptibility testing. [2] [3]

Publications

Dilnessa’s publication record includes collaborative articles appearing in journals covering infectious diseases, microbiology, antimicrobial resistance, and public health. Examples of documented publications include the following:

  • “Prevalence and antimicrobial resistance pattern of Clostridium difficile among hospitalized diarrheal patients: A systematic review and meta-analysis,” published in PLoS ONE in 2022. [4]
  • “Evaluation of wet mount and concentration techniques of stool examination for intestinal parasites identification at Debre Markos Comprehensive Specialized Hospital, Ethiopia,” published in Infection and Drug Resistance in 2021. [2]
  • “Methicillin and inducible clindamycin resistance in clinical Staphylococcus aureus isolates: a cross-sectional study from Northwest Ethiopia,” published in Frontiers in Microbiology in 2025. [5]

Research Impact

According to the academic metrics supplied for this recognition profile, Dilnessa has accumulated 1,174 citations, an h-index of 16, and an i10-index of 22. These indicators provide quantitative measures of the visibility and citation activity associated with his scholarly publications. Citation metrics can vary between databases and over time; therefore, the figures should be interpreted in relation to the relevant indexing platform and the date on which the profile was assessed. [1] [5]

Beyond numerical indicators, the subject areas represented in his publications demonstrate sustained engagement with infectious disease and microbiological research. Studies addressing antimicrobial resistance, tuberculosis, bacterial infections, and laboratory diagnosis have practical relevance to healthcare systems and public-health surveillance, particularly in settings where locally generated microbiological evidence is important.

Award Suitability

The research profile of Tebelay Dilnessa is aligned with the scientific scope of an Innovative Molecular Biologist Award through its emphasis on microbiology, infectious disease research, antimicrobial resistance, pathogen investigation, and laboratory science. His body of work demonstrates sustained participation in collaborative research addressing microbiological problems with clinical and public-health relevance.

The documented combination of primary research, systematic evidence synthesis, laboratory investigation, and publication activity provides a scholarly basis for recognition within a microbiology-focused molecular biology awards framework. The award designation presented on this page is associated with the International Molecular Biologist Awards and should be understood as an academic recognition profile rather than an independent bibliometric ranking. [2] [4]

Conclusion

Tebelay Dilnessa is a microbiology researcher affiliated with Debre Markos University whose scholarly work encompasses antimicrobial resistance, infectious diseases, tuberculosis, bacterial pathogens, diagnostic microbiology, and evidence synthesis. His publications contribute to the scientific literature through laboratory-based investigations and collaborative studies addressing clinically and epidemiologically important microbiological questions.

Based on the supplied academic profile and documented publication activity, his research represents a sustained contribution to microbiology and related biomedical research areas. His ORCID, Scopus, and Google Scholar profiles provide additional routes for examining his scholarly record and current research output.

References

  1. Elsevier. (n.d.). Scopus author details: Tebelay Dilnessa, Author ID 57190571702. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57190571702
  2. Dove Medical Press. (n.d.). Tebelay Dilnessa — Author Profile and Published Papers. Dove Medical Press.
    https://www.dovepress.com/author-profile/966185
  3. ORCID. (n.d.). Tebelay Dilnessa — ORCID record. ORCID.
    https://orcid.org/0000-0002-3713-6783
  4. Dilnessa, T., Getaneh, A., Hailu, W., Moges, F., & Gelaw, B. (2022). Prevalence and antimicrobial resistance pattern of Clostridium difficile among hospitalized diarrheal patients: A systematic review and meta-analysis.
    https://doi.org/10.1371/journal.pone.0262597
  5. Addis, Z., Aschale, Y., Fenta, A., Teffera, Z. H., Melkamu, A., Tigab, A., & Dilnessa, T. (2025). Methicillin and inducible clindamycin resistance in clinical Staphylococcus aureus isolates: a cross-sectional study from Northwest Ethiopia. Frontiers in Microbiology,.
    https://doi.org/10.3389/fmicb.2025.1569242

Seyed Hossein Shahcheraghi | Molecular Pharmacology | Innovative Molecular Biologist Award

Published on by Molecular Biologist

Innovative Molecular Biologist Award

Seyed Hossein Shahcheraghi
Yazd Shahid Sadoughi University of Medical Sciences Campus, Iran

Seyed Hossein Shahcheraghi
Affiliation Yazd Shahid Sadoughi University of Medical Sciences Campus
Country Iran
Scopus ID 55935316300
Documents 75
Citations 820
h-index 13
Subject Area Molecular Pharmacology
Event International Molecular Biologist Awards
ORCID 0000-0003-1399-5222

Seyed Hossein Shahcheraghi is a researcher affiliated with Yazd Shahid Sadoughi University of Medical Sciences Campus in Iran, with a stated subject-area focus in molecular pharmacology. These bibliometric indicators provide a quantitative overview of the research record and are presented here as profile information rather than as an independent assessment of scientific quality.[1] [2]

Abstract

This academic recognition profile presents the research record of Seyed Hossein Shahcheraghi, affiliated with Yazd Shahid Sadoughi University of Medical Sciences Campus, Iran. The stated research subject area is molecular pharmacology, a field concerned with molecular and cellular mechanisms underlying pharmacological activity, drug action, and therapeutic response. The available Scopus profile reports 75 documents, 820 citations, and an h-index of 13.[1] The profile is additionally associated with ORCID identifier 0000-0003-1399-5222.[2] On the basis of the supplied bibliometric information and stated research area, the researcher is presented in connection with the Innovative Molecular Biologist Award under the International Molecular Biologist Awards.

Keywords

Keywords: Seyed Hossein Shahcheraghi; Molecular Pharmacology; Molecular Biology; Pharmacology; Biomedical Research; Research Impact; Bibliometrics; Scopus; ORCID; Innovative Molecular Biologist Award.

Introduction

Molecular pharmacology examines pharmacological phenomena at the molecular and cellular levels, linking biological mechanisms with the actions of drugs and other bioactive compounds. Modern pharmacological research increasingly incorporates molecular targets, signaling pathways, cellular responses, and mechanisms that influence therapeutic activity. The identification and characterization of molecular targets are consequently important components of contemporary drug discovery and pharmacological investigation.[4]

Within this broader scientific context, the research profile of Seyed Hossein Shahcheraghi is identified with molecular pharmacology and is associated with Yazd Shahid Sadoughi University of Medical Sciences Campus in Iran. The bibliographic indicators supplied for the profile provide a measurable description of publication activity and citation influence within indexed scholarly literature.[1]

Research Profile

The researcher’s stated subject area is Molecular Pharmacology. The supplied Scopus information identifies the researcher with Author ID 55935316300 and records 75 documents, 820 citations, and an h-index of 13.[1] These values are bibliometric descriptors of the indexed research record and may change as additional publications and citations are incorporated into bibliographic databases.

  • Researcher: Seyed Hossein Shahcheraghi
  • Institution: Yazd Shahid Sadoughi University of Medical Sciences Campus
  • Country: Iran
  • Primary subject area: Molecular Pharmacology
  • Scopus documents: 75
  • Scopus citations: 820
  • h-index: 13
  • ORCID: 0000-0003-1399-5222

The ORCID identifier provides a persistent researcher identifier intended to support reliable attribution of scholarly works and distinguish researchers across systems.[2] Used alongside bibliographic identifiers such as Scopus Author ID, persistent identifiers can assist in organizing and validating scholarly records.

Research Contributions

The available information places Shahcheraghi’s research within molecular pharmacology. At this level of description, the most appropriate characterization is a field-based one rather than a claim concerning a particular molecular pathway, therapeutic target, disease model, or individual discovery, because those details are not specified in the supplied researcher profile.

Molecular pharmacology encompasses the study of interactions between pharmacologically active molecules and biological systems. Research in this area may connect molecular targets with cellular mechanisms and pharmacological outcomes, contributing to the broader understanding of drug action and therapeutic development.[4] The researcher’s stated subject-area classification therefore provides the principal basis for describing the scientific domain represented in this recognition profile.

Publications

The supplied bibliometric record reports 75 documents indexed under the researcher’s Scopus Author ID. This publication count represents the document total provided for the profile at the time of preparation and should be understood as a database-derived indicator rather than a complete independent bibliography of every scholarly work associated with the researcher.[1]

A publication-level assessment would ordinarily examine article titles, journals, publication dates, co-authorship, citation patterns, research topics, and persistent identifiers such as DOI records. No individual publication list or researcher-specific DOI information was supplied for this page; therefore, no specific article is attributed to Shahcheraghi without an independently verified bibliographic record.

Research Impact

The supplied Scopus profile reports 820 citations and an h-index of 13.[1] Citation counts provide one quantitative measure of how frequently indexed scholarly documents have been cited, while the h-index combines publication and citation information into a single bibliometric indicator. Such measures are useful for describing research visibility but do not, by themselves, establish the quality, originality, or practical significance of individual research contributions.

The reported document and citation figures provide a quantitative basis for recognizing an established publication record within indexed literature. They should nevertheless be interpreted in relation to disciplinary practices, publication age, database coverage, authorship patterns, and other qualitative evidence when making a comprehensive assessment of research influence.

Award Suitability

The profile is presented in connection with the Innovative Molecular Biologist Award under the International Molecular Biologist Awards. The stated field of Molecular Pharmacology provides a direct connection to molecular-level biological research, while the reported Scopus record supplies quantitative evidence of sustained scholarly publication and citation activity.[1]

On the information provided, the recognition profile can be framed around three principal elements: an identified academic affiliation, a defined molecular pharmacology subject area, and a documented bibliometric record. The award suitability statement is therefore descriptive of the supplied profile and does not constitute an independent peer-review judgment or a claim of comparative superiority over other researchers.

Conclusion

Seyed Hossein Shahcheraghi is identified with Yazd Shahid Sadoughi University of Medical Sciences Campus, Iran, and with the research area of Molecular Pharmacology. The supplied Scopus profile reports 75 documents, 820 citations, and an h-index of 13, while ORCID provides the persistent identifier 0000-0003-1399-5222.[1] [2]

These identifiers and bibliometric indicators establish the principal factual basis of this academic recognition page. In the context of the International Molecular Biologist Awards, the profile supports presentation under the Innovative Molecular Biologist Award while maintaining a distinction between documented bibliometric information and broader qualitative judgments concerning scientific achievement.

References

  1. Elsevier. (n.d.). Scopus author details: Seyed Hossein Shahcheraghi, Author ID 55935316300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55935316300
  2. ORCID. (n.d.). Seyed Hossein Shahcheraghi — ORCID record. ORCID.
    https://orcid.org/0000-0003-1399-5222
  3. International Molecular Biologist Awards. (n.d.). International Molecular Biologist Awards.
    https://molecularbiologist.org/
  4. Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., & Overington, J. P. (2017). A comprehensive map of molecular drug targets. Nature Reviews Drug Discovery, 16, 19–34.
    https://doi.org/10.1038/nrd.2016.230
  5. Molecular pharmacology and drug-target research. DOI-linked scholarly literature concerning molecular drug targets and pharmacological mechanisms.
    https://doi.org/10.1038/nrd.2016.116

Alexei Tumanov | Immunology | Innovative Research Award

Published on by Molecular Biologist

Innovative Research Award

Alexei Tumanov
The University of Texas at San Antonio, United States

Alexei Tumanov
Affiliation The University of Texas at San Antonio
Country United States
Google Scholar ID EDMA9agAAAAJ
Documents 97
Citations 7,514
h-index 41
Subject Area Immunology
Event International Molecular Biologist Awards
ORCID 0000-0001-6042-0152
Scopus 35351917100

Alexei Tumanov is an immunology researcher affiliated with the University of Texas at San Antonio and the Department of Microbiology, Immunology and Molecular Genetics at UT Health San Antonio. Institutional and bibliographic sources describe his research in relation to cytokine signaling, lymphotoxin biology, immune regulation, lymphoid-organ biology, inflammation, cancer immunotherapy and neuroimmune mechanisms.[1][2]

Abstract

Alexei Tumanov’s research profile is centered on molecular and cellular immunology, with particular emphasis on lymphotoxin signaling and its relationship to immune-system organization, inflammatory responses and disease mechanisms. His institutional research record includes investigations of lymphotoxin-beta receptor signaling, innate and adaptive immune responses, cancer immunotherapy and neuroimmune interactions.[1] Recent publications have examined lymphotoxin-beta receptor regulation of chronic pain, ferroptosis-associated regulation of innate lymphoid cell responses, and strategies intended to separate antitumor activity from immune-mediated toxicity in CD137-directed cancer immunotherapy.[2][3]

Keywords

  • Immunology
  • Molecular Immunology
  • Lymphotoxin Signaling
  • Lymphotoxin-beta Receptor
  • Cytokine Biology
  • Innate Immunity
  • Cancer Immunotherapy
  • Neuroimmune Regulation
  • Inflammation

Introduction

Molecular immunology examines how signaling pathways, immune-cell interactions and tissue environments regulate protective immunity and inflammatory disease. Within this field, lymphotoxin signaling represents an important area for studying the organization and maintenance of lymphoid tissues and the communication between immune and non-immune cells. Tumanov’s research has addressed these mechanisms through experimental studies of lymphotoxin pathways and their roles in immune-system development and disease-related processes.[1]

His earlier work included conditional targeting studies of lymphotoxin pathways in lymphoid organs. Such research contributed to the characterization of cell-specific functions of lymphotoxin and lymphotoxin-beta receptor signaling in peripheral lymphoid-organ development and maintenance.[4] More recent work has extended this research framework to inflammatory bowel disease, cancer immunotherapy and neuroimmune signaling.[2][3]

Research Profile

Institutional information identifies Tumanov as a researcher in the Department of Microbiology, Immunology and Molecular Genetics at UT Health San Antonio. His documented research interests include immune regulation, cytokine signaling and lymphotoxin biology. His research profile also encompasses interactions between immune pathways and pathological processes, including inflammation, cancer and chronic pain.[1][2]

The research program has included both fundamental and disease-oriented investigations. Earlier studies examined lymphotoxin-dependent organization of lymphoid organs, while later studies have investigated how related signaling mechanisms can influence therapeutic toxicity, inflammatory responses and sensory-neural processes.[4][5]

Research Contributions

A central contribution of Tumanov’s research is the investigation of lymphotoxin-beta receptor signaling as a regulator of immune and tissue processes. Experimental work has examined how this receptor pathway contributes to lymphoid-organ development and maintenance and how alterations in the pathway can affect inflammatory and pathological responses.[4]

In cancer immunotherapy, Tumanov has investigated mechanisms associated with the toxicity of CD137-directed treatment. A Cancer Prevention and Research Institute of Texas grant lists him as principal investigator for a project examining the role of lymphotoxin-beta receptor signaling in overcoming liver toxicity associated with anti-CD137 cancer immunotherapy.[5]

His recent collaborative research has also examined neuroimmune mechanisms. A 2026 Cell Reports publication reported that lymphotoxin-beta receptor signaling is involved in the development of chronic pain, providing experimental evidence connecting an immune signaling pathway with sensory processes.[3]

Additional work published in Cellular & Molecular Immunology examined ferroptosis in relation to ILC2 responses in inflammatory bowel disease. The article identifies lymphotoxin-related immunological research within a broader investigation of inflammatory mechanisms affecting innate lymphoid cells.[2]

Publications

Tumanov’s publication record spans molecular immunology, cytokine signaling, lymphoid-organ biology, inflammatory disease, cancer immunotherapy and neuroimmune regulation. His institutional profile lists publications including recent studies in Science Advances, Cell Reports and Cellular & Molecular Immunology.[1]

  • Tumanov, A. V., et al. (2026). Lymphotoxin-beta receptor controls the development of chronic pain. Cell Reports, 45(4), 117269. DOI: 10.1016/j.celrep.2026.117269.[3]
  • Korchagina, A. A., & Tumanov, A. V. (2026). Ferroptosis shapes ILC2 responses in inflammatory bowel disease. Cellular & Molecular Immunology, 23, 583–585. DOI: 10.1038/s41423-026-01404-z.[2]
  • Shein, S. A., Korchagina, A. A., Wang, L.-J., et al., including Tumanov, A. V. (2026). Selective elimination of circulating effector CD8 T cells via LTβR blockade separates anti-CD137 efficacy from toxicity. Science Advances, 12(17), eaea8737.[1]
  • Tumanov, A. V., et al. (2003). Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunological Reviews. DOI: 10.1034/j.1600-065X.2003.00071.x.[4]

Research Impact

The documented research program connects fundamental immunological mechanisms with disease-oriented questions. Institutional records describe grant-supported research into the regulation of cancer immunotherapy toxicity and the role of lymphotoxin-beta receptor signaling in sensory neurons, while recent publications extend the research into chronic pain and inflammatory bowel disease.[2][3][5]

The quantitative metrics supplied for this recognition profile list 97 documents, 7,514 citations and an h-index of 41. Such metrics are bibliographic indicators and should be interpreted according to the database, date of retrieval and author-profile methodology used. The supplied Google Scholar, ORCID and Scopus identifiers provide external routes for verification and updating of these records.

The translational relevance of the research is also reflected in grant-supported projects. CPRIT records identify Tumanov as principal investigator of research concerning anti-CD137 cancer immunotherapy and lymphotoxin-beta receptor signaling, illustrating an application-oriented dimension of his immunological research.[5]

Award Suitability

The documented research themes are closely associated with molecular and cellular immunology, including cytokine signaling, lymphotoxin biology, immune-cell regulation and disease mechanisms. His publication record and institutionally documented research projects provide identifiable evidence of sustained activity in these areas.[1][5]

For the purposes of the International Molecular Biologist Awards, the supplied recognition category is the Innovative Research Award. This article records the relationship between the stated award category and the documented research profile without assigning an independent assessment of scientific merit.

Conclusion

Alexei Tumanov’s research profile encompasses molecular immunology, lymphotoxin signaling and the regulation of immune responses in physiological and pathological settings. His documented work includes studies of lymphoid-organ biology, inflammatory disease, cancer immunotherapy and neuroimmune mechanisms. Recent publications demonstrate continuing investigation of lymphotoxin-beta receptor pathways and immune-cell regulation, while grant records document support for translational research involving cancer immunotherapy.[1][2][3][5]

References

  1. UT Health San Antonio. (n.d.). Tumanov, Alexei, M.D., Ph.D. — Microbiology, Immunology & Molecular Genetics. Institutional researcher profile.
    https://lsom.uthscsa.edu/mimg/team-member/alexei-v-tumanov-m-d-ph-d/
  2. Korchagina, A. A., & Tumanov, A. V. (2026). Ferroptosis shapes ILC2 responses in inflammatory bowel disease. Cellular & Molecular Immunology, 23, 583–585. DOI: 10.1038/s41423-026-01404-z.
    https://doi.org/10.1038/s41423-026-01404-z
  3. Tumanov, A. V., Mecklenburg, J. M., Belugin, S., et al. (2026). Lymphotoxin-beta receptor controls the development of chronic pain. Cell Reports, 45(4), 117269. DOI: 10.1016/j.celrep.2026.117269.
    https://doi.org/10.1016/j.celrep.2026.117269
  4. Tumanov, A. V., et al. (2003). Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunological Reviews. DOI: 10.1034/j.1600-065X.2003.00071.x.
    https://doi.org/10.1034/j.1600-065X.2003.00071.x
  5. Cancer Prevention and Research Institute of Texas. (2022). Grant RP220470: Overcoming liver toxicity of anti-CD137 cancer immunotherapy. Principal Investigator: Alexei Tumanov. University of Texas Health Science Center at San Antonio.
    https://www.cprit.texas.gov/grants-funded/grants/rp220470

Mehmet Kizilkaya | Cancer Biology | Innovative Research Award

Published on by Molecular Biologist

Innovative Research Award

Mehmet Kizilkaya
Researcher Mehmet Kizilkaya
Affiliation Trabzon Kanuni Training and Research Hospital
Country Turkey
Google Scholar ID LoT5L1kAAAAJ
Documents 1
Citations 1
h-index 0
Subject Area Cancer Biology
Event International Molecular Biologist Awards
ORCID 0000-0003-0266-3919

Mehmet Kizilkaya

Trabzon Kanuni Training and Research Hospital, Turkey

Mehmet Kizilkaya and places his documented publication activity within the broader field of cancer-related research. The Innovative Research Award recognizes research activity involving novel approaches, scientific problem solving, and contributions to the development or application of knowledge.[1][2]

Abstract

Mehmet Kizilkaya is presented in this recognition profile as a researcher working in the cancer biology and oncology-related research domain. The supplied academic record lists one document, one citation, and an h-index of zero. A publicly indexed publication bearing his name addresses the screening of oncology patients for COVID-19 before radiotherapy, while another indexed article lists him as a co-author on research examining dosimetric effects during radiotherapy for gynecologic cancer.[1][2]

Keywords

Cancer Biology, Oncology, Radiation Oncology, Radiotherapy, Gynecologic Cancer, Cancer Research, Clinical Research, Medical Research, Dosimetry, Innovative Research.

Introduction

Cancer research encompasses biological, clinical, diagnostic, therapeutic, and technological investigations directed toward improving the understanding and management of malignant disease. Radiation oncology represents an interdisciplinary component of cancer care in which treatment planning, imaging, dosimetry, and patient-specific clinical considerations are integrated into radiotherapy practice. The documented publications associated with Mehmet Kizilkaya include research concerning oncology patients undergoing radiotherapy and treatment-planning considerations in gynecologic cancer.[1][2]

Research Profile

The supplied profile identifies Mehmet Kizilkaya with Trabzon Kanuni Training and Research Hospital in Turkey and places the research subject area within Cancer Biology. His publicly indexed scholarly record includes oncology-related research performed in the context of radiation oncology. An institutional academic record associated with the same name lists publications involving radiotherapy, oncology patients, and treatment dosimetry.[1][2]

  • Research area supplied for this recognition profile: Cancer Biology.
  • Research themes documented in indexed publications include oncology and radiation oncology.
  • Scholarly work includes clinical and treatment-related research involving cancer patients.
  • Google Scholar profile identifier: LoT5L1kAAAAJ.

Research Contributions

One documented contribution is the 2022 publication Results of Screening Oncology Patients for COVID-19 Before Radiotherapy: Single Center Experience. The article reports a single-center screening experience involving oncology patients before radiotherapy and considers the prevention of infectious transmission in the cancer-treatment setting.[1]

A further publication, appearing in the Turkish Journal of Oncology in 2025, lists Mehmet Kizilkaya among its authors and examines the dosimetric effects of bladder and rectum filling in patients with gynecologic cancer receiving adjuvant radiotherapy. The study was published with DOI 10.5505/tjo.2024.4429.[2]

Publications

  • Results of Screening Oncology Patients for COVID-19 Before Radiotherapy: Single Center Experience. UHOD / International Journal of Hematology and Oncology, 2022, 32(3), 188–190. DOI: 10.4999/uhod.226389.[1]
  • Evaluation of the Dosimetric Effects of Bladder and Rectum Filling in Patients with Gynecologic Cancer Receiving Adjuvant Radiotherapy. Turkish Journal of Oncology, 2025, 40(1), 11–19. DOI: 10.5505/tjo.2024.4429.[2]

The publication record should be interpreted together with the researcher’s complete scholarly profile because individual database records may differ in coverage, indexing dates, author disambiguation, and citation updating. The supplied Google Scholar profile is therefore included as an external source for continued verification of publication activity.[3]

Research Impact

The supplied bibliometric information records one document, one citation, and an h-index of zero. These values represent the information provided for this award profile and should not be interpreted as a complete assessment of scientific influence. Citation-based indicators are dependent on database coverage, publication age, field-specific citation practices, and the timing of database updates.[3]

The documented oncology publications nevertheless provide evidence of participation in clinical research addressing radiotherapy practice and cancer-patient management. The 2025 dosimetric study, for example, investigated the relationship between bladder and rectum filling and radiation-treatment planning parameters in gynecologic cancer patients.[2]

Award Suitability

The Innovative Research Award profile is based on documented research participation, subject relevance, publication activity, and the supplied academic identifiers. Mehmet Kizilkaya’s indexed work concerns clinically relevant oncology and radiotherapy questions, including cancer-patient screening and treatment dosimetry.[1][2] Final award decisions, however, remain matters for the designated award evaluation and review process.

Conclusion

Mehmet Kizilkaya’s documented research activity includes contributions to oncology and radiation-oncology research. His identified publications address practical clinical questions involving radiotherapy and cancer patients, while the supplied academic profile provides corresponding scholarly identifiers and bibliometric information. These records form the documentary basis for this academic recognition page.[1][2][3]

References

  1. Kizilkaya, M., Genc, M., Aksu, M. G., Koca, T., & Korcum, A. F. (2022). Results of Screening Oncology Patients for COVID-19 Before Radiotherapy: Single Center Experience. International Journal of Hematology and Oncology, 32(3), 188–190.
    https://doi.org/10.4999/uhod.226389
  2. Koca, T., Aksoy, R. A., Atak, E., Kizilkaya, M., Bilek, Y., Tunçel, N., Sarpün, İ. H., & Korcum, A. F. (2025). Evaluation of the Dosimetric Effects of Bladder and Rectum Filling in Patients with Gynecologic Cancer Receiving Adjuvant Radiotherapy. Turkish Journal of Oncology, 40(1), 11–19.
    https://doi.org/10.5505/tjo.2024.4429
  3. Google Scholar. (n.d.). Mehmet Kizilkaya — Google Scholar profile. Google Scholar.
    https://scholar.google.com/citations?user=LoT5L1kAAAAJ&hl=tr
  4. ORCID. (n.d.). Mehmet Kizilkaya — ORCID record. ORCID.
    https://orcid.org/0000-0003-0266-3919
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/

Filiz AKIN | Fertigation | Innovative Research Award

Published on by Molecular Biologist

Innovative Research Award

Filiz AKIN
Researcher Filiz AKIN
Affiliation West Mediterranean Agricultural Research Institute
Country Turkey
Google Scholar ID TGzn7U8AAAAJ
Documents 2
Citations 25
h-index 3
Subject Area Fertigation
Event International Molecular Biologist Awards
ORCID 0000-0002-0902-475X
Scopus 59979471900

Filiz AKIN

West Mediterranean Agricultural Research Institute, Turkey

Filiz AKIN, a researcher affiliated with the West Mediterranean Agricultural Research Institute in Turkey. Her listed subject area is fertigation, an agricultural management approach involving the application of nutrients through irrigation systems. The Innovative Research Award recognizes research activities that introduce new approaches, improve established methodologies, or contribute to the development of practical solutions within a scientific discipline. [1][2]

Abstract

Filiz AKIN is affiliated with the West Mediterranean Agricultural Research Institute in Turkey and is associated with the subject area of fertigation. The supplied scholarly profile records two documents, 25 citations, and an h-index of 3. These indicators provide a limited quantitative overview of the researcher’s indexed scholarly activity. A fuller assessment of research significance requires examination of individual publications, methodologies, findings, and contributions to agricultural science.[1][2]

Keywords

Filiz AKIN, Innovative Research Award, Fertigation, Agricultural Research, Irrigation Management, Nutrient Application, Sustainable Agriculture, Agricultural Engineering, Scholarly Publications, Research Impact.

Introduction

Fertigation refers to the application of dissolved plant nutrients through irrigation systems. The approach can support the coordinated management of water and nutrient delivery, although its effectiveness depends on crop requirements, irrigation uniformity, soil characteristics, nutrient compatibility, and appropriate management practices.[3]

Research in this area contributes to the broader study of agricultural productivity, resource-use efficiency, and sustainable crop production. The evaluation of innovative agricultural research generally considers the scientific rationale, experimental design, reproducibility, practical relevance, and the extent to which findings advance existing knowledge.[3][4]

Research Profile

The available profile identifies Filiz AKIN as a researcher affiliated with the West Mediterranean Agricultural Research Institute. Her listed research subject is fertigation, which is situated at the intersection of irrigation science, plant nutrition, soil management, and agricultural engineering.

  • Researcher: Filiz AKIN.
  • Institution: West Mediterranean Agricultural Research Institute.
  • Country: Turkey.
  • Subject area: Fertigation.
  • Reported scholarly documents: 2.
  • Reported citations: 25.
  • Reported h-index: 3.

The supplied researcher identifiers include a Google Scholar profile, an ORCID record, and a Scopus author profile. These identifiers can assist with distinguishing scholarly records and locating additional information about publications and research activities.[1][2]

Research Contributions

Fertigation research may address the optimization of nutrient delivery, irrigation scheduling, fertilizer-use efficiency, crop response, and the management of agricultural inputs. Such investigations can support evidence-based decisions concerning irrigation and plant nutrition when supported by appropriate experimental data.[3]

The available information associates Filiz AKIN with fertigation research; however, it does not provide sufficient publication-level evidence to identify specific experiments, crop systems, technologies, or original findings. Accordingly, detailed claims concerning individual scientific contributions should be based on verified articles and institutional research records.

Publications

The supplied scholarly profile reports two documents associated with the researcher. The available information does not include the titles, publication dates, journals, co-authors, abstracts, or digital object identifiers of those documents.

  • Reported number of documents: 2.
  • Reported citation count: 25.
  • Reported h-index: 3.

For accurate bibliographic evaluation, publication details should be checked against the researcher’s indexed records and the original publisher pages. No specific publication DOI has been supplied for inclusion in this profile.

Research Impact

The reported citation count and h-index offer quantitative indicators of scholarly visibility. The h-index is a bibliometric measure that combines publication output and citation frequency, but it should not be interpreted as a complete measure of research quality or societal benefit.[4]

In agricultural research, impact may also be assessed through the practical adoption of technologies, improvements in resource-use efficiency, contributions to sustainable production, collaboration with agricultural institutions, and the reproducibility of scientific findings. These dimensions require evidence beyond the numerical indicators provided in the current profile.[3]

Award Suitability

The Innovative Research Award is relevant to research that demonstrates originality, methodological development, scientific value, or practical innovation. Filiz AKIN’s stated association with fertigation provides a subject-area basis for consideration within agricultural and applied research categories.

The reported scholarly indicators may be considered as part of an academic evaluation, but they do not independently establish the originality or significance of particular research findings. A comprehensive award assessment should include verified publications, research contributions, peer-reviewed evidence, institutional affiliation, and the criteria established by the International Molecular Biologist Awards.[4][5]

Conclusion

Filiz AKIN is identified as a researcher affiliated with the West Mediterranean Agricultural Research Institute in Turkey, with a listed subject area of fertigation. The supplied profile reports two documents, 25 citations, and an h-index of 3. These details provide a concise overview of the researcher’s reported scholarly activity. Further evaluation of innovative research contributions would require examination of the underlying publications and their scientific or practical significance.

References

  1. Elsevier. (n.d.). Scopus author details: Filiz AKIN, Author ID 59979471900. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59979471900
  2. Google Scholar. (n.d.). Scholar profile of Filiz AKIN. Google Scholar.
    https://scholar.google.co.uk/citations?user=TGzn7U8AAAAJ&hl=en&oi=ao
  3. Food and Agriculture Organization of the United Nations. (n.d.). Fertigation and irrigation management in agricultural production. FAO.
    https://www.fao.org/land-water/water/water-efficiency/en/
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/

Karim Echtay | Biochemistry | Innovative Research Award

Published on by Molecular Biologist

Innovative Research Award

Karim Echtay
Researcher Karim Echtay
Affiliation University of Balamand
Country Lebanon
Scopus ID 6602196767
Documents 36
Citations 4,853
h-index 25
Subject Area Biochemistry
Event International Molecular Biologist Awards
ORCID 0000-0002-2134-5804
Google Scholar 6oTANJMAAAAJ

Karim Echtay

University of Balamand, Lebanon

Karim Echtay is a researcher affiliated with the University of Balamand in Lebanon whose academic profile is associated with the field of biochemistry. His scholarly record includes 36 documents, 4,853 citations, and an h-index of 25, according to the supplied research-profile information. These indicators provide a quantitative overview of his publication activity and citation visibility within the scientific literature.[1]

Abstract

This article presents an academic recognition profile of Karim Echtay, a researcher affiliated with the University of Balamand, Lebanon. His stated subject area is biochemistry, and his supplied bibliometric record includes 36 documents, 4,853 citations, and an h-index of 25. The profile discusses the relevance of scholarly productivity, citation-based indicators, and research innovation to academic recognition. While bibliometric measures can help describe research visibility, they do not independently establish the originality, quality, or practical significance of individual studies.[1][2]

Keywords

Karim Echtay, Innovative Research Award, Biochemistry, University of Balamand, Lebanon, Scientific Research, Scholarly Publications, Citation Impact, Research Evaluation, Academic Recognition, Research Innovation.

Introduction

Biochemistry examines the chemical processes and molecular mechanisms underlying biological systems. Research in this field contributes to understanding biological functions, molecular interactions, metabolic pathways, disease mechanisms, and the development of scientific and biomedical applications. Academic contributions may be assessed through peer-reviewed publications, methodological advances, reproducibility, collaboration, and the relevance of research findings to a particular scientific problem.

The evaluation of research performance frequently incorporates bibliometric indicators. Citation counts provide information about the number of recorded citations associated with a researcher’s publications, whereas the h-index combines publication and citation information into a single indicator. Such measures should be interpreted in relation to disciplinary practices, career stage, publication types, and the time period covered by the relevant database.[2][3]

Research Profile

Karim Echtay is identified in the supplied information as a researcher at the University of Balamand in Lebanon. His stated academic subject area is biochemistry. The following details summarize the research-profile information provided for this article.

  • Researcher: Karim Echtay.
  • Institution: University of Balamand.
  • Country: Lebanon.
  • Subject area: Biochemistry.
  • Scopus Author ID: 6602196767.
  • Reported documents: 36.
  • Reported citations: 4,853.
  • Reported h-index: 25.

The reported Scopus identifier provides a means of locating the corresponding author record in the Scopus database. Author-profile information can be used to examine indexed publications, citation records, and related bibliometric information, subject to database coverage and profile accuracy.[1]

Research Contributions

The supplied information identifies biochemistry as Karim Echtay’s principal subject area. Biochemical research may involve the investigation of molecular structures, enzyme activity, cellular processes, protein function, metabolic regulation, and the chemical basis of biological phenomena. However, the specific research themes, experimental methods, and individual scientific contributions associated with the researcher cannot be established solely from the supplied bibliometric indicators.

A complete assessment of research contributions would require examination of the researcher’s publications, including their objectives, methods, findings, limitations, and relationship to previous literature. Particular attention may be given to the originality of research questions, methodological rigor, reproducibility, and the extent to which findings advance understanding within biochemistry.

Publications

The supplied profile reports 36 scholarly documents associated with Karim Echtay. These records may include different publication types, depending on the classification used by the relevant indexing database. A detailed publication analysis would require verification of individual titles, authorship, journal information, publication dates, document types, and subject classifications.

  • Reported publication documents: 36.
  • Reported research subject: Biochemistry.
  • Publication records may be examined through the supplied Scopus author profile.
  • Individual publication titles and DOI identifiers require verification before being included as confirmed research outputs.

No specific publication titles or verified DOI records were supplied for this article. Accordingly, no individual paper is attributed to the researcher here without additional bibliographic confirmation.

Research Impact

The supplied bibliometric information reports 4,853 citations and an h-index of 25 for Karim Echtay. Citation counts can indicate the extent to which published research has been referenced in subsequent scholarly work. The h-index is intended to summarize a combination of publication productivity and citation impact, although its interpretation varies among disciplines and research communities.[2][3]

Bibliometric indicators should be considered alongside qualitative evidence, including the significance of research findings, contributions to scientific methods, collaboration, mentorship, research integrity, and practical or theoretical applications. Citation-based measures alone do not establish the quality or originality of a researcher’s work.[3]

Award Suitability

The Innovative Research Award is intended to recognize research associated with originality, scientific advancement, and meaningful contributions to a defined field. Karim Echtay’s supplied academic profile includes an affiliation with the University of Balamand, a stated specialization in biochemistry, and reported bibliometric indicators of 36 documents, 4,853 citations, and an h-index of 25.

These details may provide contextual information for an academic recognition process. A substantive award assessment should additionally consider verified publications, research originality, methodological quality, the significance of findings, independent scholarly evaluation, and the specific eligibility criteria established by the awarding organization. The information presented in this article does not constitute an independent adjudication of award eligibility or selection.

Conclusion

Karim Echtay is identified as a biochemistry researcher affiliated with the University of Balamand in Lebanon. The supplied research profile reports 36 documents, 4,853 citations, and an h-index of 25. These indicators provide a quantitative description of scholarly activity and citation visibility. Further evaluation of research innovation and scientific contribution would require examination of verified publications and qualitative evidence. The profile is presented in connection with the Innovative Research Award of the International Molecular Biologist Awards.

References

  1. Elsevier. (n.d.). Scopus author details: Karim Echtay, Author ID 6602196767. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6602196767
  2. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  3. Hicks, D., Wouters, P., Waltman, L., de Rijcke, S., & Rafols, I. (2015). Bibliometrics: The Leiden Manifesto for research metrics. Nature, 520, 429–431.
    https://doi.org/10.1038/520429a
  4. ORCID. (n.d.). ORCID record: Karim Echtay. ORCID.
    https://orcid.org/0000-0002-2134-5804
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/

Tamara Sakhno | Enzymology | Research Excellence Award

Published on by Molecular Biologist

Research Excellence Award

              Tamara Sakhno
Researcher Tamara Sakhno
Affiliation Poltava University of Economics and Trade
Country Ukraine
Scopus ID 7003968703
Documents 54
Citations 286
h-index 9
Subject Area Enzymology
Event International Molecular Biologist Awards
ORCID 0000-0001-7049-4657
Google Scholar 0JNwwgYAAAAJ

Tamara Sakhno

Poltava University of Economics and Trade, Ukraine

Tamara Sakhno, whose stated subject area is Enzymology. The Research Excellence Award recognizes researchers whose scholarly activity demonstrates sustained contribution to scientific knowledge, publication activity, research visibility, and measurable academic impact. This academic recognition profile presents the publicly identified research information associated with publication output and bibliometric indicators as complementary measures of scholarly activity rather than as a substitute for qualitative peer evaluation.[1]

Abstract

Tamara Sakhno is a researcher affiliated with Poltava University of Economics and Trade in Ukraine. Her academic profile is identified with the field of Enzymology and is represented in the Scopus database by Author ID 7003968703. The supplied bibliometric record lists 54 documents, 286 citations, and an h-index of 9. These indicators provide a quantitative overview of research visibility and publication activity and should be interpreted alongside the content, originality, and significance of individual scholarly contributions.[1]

Keywords

Tamara Sakhno, Research Excellence Award, Enzymology, enzyme research, biochemical sciences, scientific publications, research impact, bibliometrics, Scopus, ORCID, scholarly communication, Ukraine.

Introduction

Enzymology is a branch of biochemical science concerned with enzymes, their catalytic functions, mechanisms, regulation, and applications. Research in this area contributes to the broader understanding of biological processes and can intersect with biotechnology, food science, medicine, environmental science, and industrial applications. Scholarly assessment in such fields commonly considers both qualitative research contributions and quantitative indicators of publication and citation activity.[2]

Bibliometric measures can help describe the reach of published research. The h-index, for example, was proposed as an indicator combining publication productivity with citation impact, although it has recognized limitations and should not be used as the sole measure of research quality.[3]

Research Profile

The available researcher information places Tamara Sakhno within the academic environment of Poltava University of Economics and Trade and identifies Enzymology as the principal subject area. Her researcher identifiers provide mechanisms for distinguishing her scholarly record across major academic information systems.

  • Institutional affiliation: Poltava University of Economics and Trade.
  • Country of affiliation: Ukraine.
  • Primary subject area supplied for this profile: Enzymology.
  • Scopus Author ID: 7003968703.
  • ORCID identifier: 0000-0001-7049-4657.
  • Google Scholar profile identifier: 0JNwwgYAAAAJ.

Persistent researcher identifiers such as ORCID are designed to help distinguish researchers and connect their scholarly activities across systems, while bibliographic databases such as Scopus provide structured information concerning indexed publications and citations.[1][4]

Research Contributions

Within the stated field of Enzymology, research contributions may involve investigation of enzyme activity, catalytic mechanisms, biochemical interactions, optimization of enzymatic processes, and applications of enzymes in scientific or industrial contexts. The available bibliometric record establishes a documented publication presence but does not, by itself, provide sufficient evidence to assign specific individual discoveries or claims beyond the indexed profile.

A balanced assessment of research contribution should therefore consider the subject relevance, methodological rigor, originality, reproducibility, collaboration, and practical or theoretical significance of individual publications. Citation indicators can provide supporting evidence of scholarly attention but do not independently establish the scientific quality of a research contribution.[3]

Publications

The supplied Scopus record reports 54 documents associated with Tamara Sakhno. This publication count indicates an established indexed research output. The precise titles, publication venues, authorship positions, subject classifications, and individual citation distributions should be evaluated directly through the relevant bibliographic records when a publication-level assessment is required.[1]

  • Reported Scopus-indexed documents: 54.
  • Reported citations: 286.
  • Reported h-index: 9.
  • Research area associated with the profile: Enzymology.

Research Impact

The reported total of 286 citations provides evidence that the researcher’s indexed publications have received scholarly attention. An h-index of 9 further indicates that at least nine publications in the corresponding dataset have each received at least nine citations, subject to the database’s current indexing and counting methodology.[1][3]

Citation-based indicators can vary between databases because coverage, document types, author matching, citation sources, and update schedules differ. Consequently, the reported figures should be regarded as database-specific measurements rather than fixed measures of overall scientific influence.[3]

Award Suitability

The available profile provides several factors relevant to consideration for a Research Excellence Award, including a documented publication record, measurable citation activity, an established Scopus author profile, and a defined research association with Enzymology. The reported 54 documents and 286 citations indicate sustained scholarly activity within the indexed record.[1]

For a comprehensive award evaluation, these quantitative indicators should be considered together with the originality and significance of the research, quality of publications, contribution to collaborative projects, methodological standards, and broader academic or societal relevance. Such a combined approach provides a more balanced assessment than reliance on bibliometric measures alone.[3]

Conclusion

Tamara Sakhno’s available academic profile documents research activity associated with Poltava University of Economics and Trade and the subject area of Enzymology. The reported record of 54 documents, 286 citations, and an h-index of 9 provides measurable evidence of indexed scholarly activity. These indicators, together with qualitative examination of research outputs, can form part of an evidence-based assessment for academic recognition through the International Molecular Biologist Awards.[1][5]

References

  1. Elsevier. (n.d.). Scopus author details: Tamara Sakhno, Author ID 7003968703. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7003968703
  2. National Center for Biotechnology Information. (n.d.). Enzymology and enzyme-related biomedical research resources. National Library of Medicine.
    https://www.ncbi.nlm.nih.gov/
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  4. ORCID. (n.d.). ORCID record: Tamara Sakhno, ORCID iD 0000-0001-7049-4657.
    https://orcid.org/0000-0001-7049-4657
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/

Rose-Mary Boustany | Neurobiology | Research Excellence Award

Published on by Molecular Biologist

Research Excellence Award

          Rose-Mary Boustany
Researcher Rose-Mary Boustany
Affiliation American University of Beirut
Country Lebanon
Scopus ID 7003589401
Documents 112
Citations 4,460
h-index 39
Subject Area Neurobiology
Event International Molecular Biologist Awards
ORCID 0000-0002-2066-0079
Google Scholar zFSl2I0AAAAJ

Rose-Mary Boustany

American University of Beirut, Lebanon

Rose-Mary Boustany is a researcher affiliated with the American University of Beirut whose scholarly profile is associated with the field of neurobiology. The available bibliometric record indicates a substantial body of indexed research, with 112 documents, 4,460 citations, and an h-index of 39. These indicators provide quantitative evidence of sustained scholarly activity and research visibility within the scientific literature.[1]

Abstract

The Research Excellence Award profile for Rose-Mary Boustany presents a summary of her academic affiliation, research discipline, publication record, and bibliometric indicators. Her listed subject area is neurobiology, a field concerned with the biological mechanisms underlying nervous-system structure and function. The reported Scopus record comprises 112 documents, 4,460 citations, and an h-index of 39.[1] Her researcher identity is additionally represented through ORCID and Google Scholar profiles, providing complementary routes for scholarly identification and publication discovery.[2][3]

Keywords

Rose-Mary Boustany, Neurobiology, Neuroscience, Molecular Biology, Biomedical Research, Scientific Publications, Research Impact, Bibliometrics, Citation Analysis, Academic Research.

Introduction

Research recognition commonly considers multiple dimensions of scholarly performance, including publication productivity, citation influence, research quality, originality, collaboration, and contribution to scientific knowledge. Bibliometric indicators such as citation counts and the h-index can provide standardized quantitative measures of scholarly influence, although they are most appropriately interpreted alongside qualitative assessment.[4]

Within this framework, Rose-Mary Boustany’s reported research profile provides measurable indicators of academic productivity and citation visibility. The association with the American University of Beirut places the researcher within an established academic environment for biomedical and life-science research.[1]

Research Profile

The available researcher information identifies Rose-Mary Boustany with the American University of Beirut and the subject area of neurobiology. Her indexed publication record contains 112 documents, while the reported citation count is 4,460 and the h-index is 39.[1]

  • Affiliation: American University of Beirut.
  • Country: Lebanon.
  • Research subject area: Neurobiology.
  • Scopus documents: 112.
  • Reported citations: 4,460.
  • Reported h-index: 39.

Research Contributions

Neurobiology integrates molecular, cellular, physiological, and systems-level approaches to understand the nervous system. Research within this broad field can address neuronal development, cellular signaling, neurodegeneration, synaptic mechanisms, and the molecular basis of neurological function. The research classification associated with Boustany’s profile places her scholarly record within this wider scientific domain.[1]

The reported citation profile indicates that the research record has been referenced substantially within the scholarly literature. Citation measures, however, should not be interpreted independently of publication context, field-specific citation practices, authorship, and the individual significance of particular studies.[4]

Publications

The Scopus record associated with Rose-Mary Boustany lists 112 documents. Scopus provides bibliographic and citation information that can be used to examine publication output and scholarly influence over time.[1] The researcher’s Google Scholar profile provides an additional scholarly discovery source for publications and citation information.[3]

  • 112 documents are reported in the supplied Scopus researcher record.
  • The publication record is associated with neurobiology and related biomedical research.
  • Publication discovery can be supported through Scopus, ORCID, and Google Scholar researcher identifiers.

Research Impact

The reported 4,460 citations and h-index of 39 provide quantitative indicators of the visibility of the researcher’s publications within the indexed scholarly literature.[1] The h-index was originally proposed as a metric intended to combine aspects of publication productivity and citation impact, although its interpretation varies among disciplines and career stages.[4]

Research impact may also be assessed through the quality and relevance of individual publications, contribution to scientific collaboration, methodological advances, reproducibility, and influence on subsequent research. Consequently, bibliometric indicators are best considered as one component of a broader academic evaluation.

Award Suitability

The Research Excellence Award recognizes scholarly achievement based on evidence such as research productivity, scientific visibility, and contribution to a defined academic discipline. Based on the supplied bibliometric information, Rose-Mary Boustany has a substantial indexed publication record and a reported citation profile that may be relevant to an academic recognition process.[1]

Final award decisions should be based on the criteria and independent evaluation procedures established by the organizing body. Bibliometric indicators can support such assessment but do not, by themselves, establish the quality or significance of individual research contributions.

Conclusion

Rose-Mary Boustany’s academic profile is associated with the American University of Beirut and the research area of neurobiology. The supplied Scopus information reports 112 documents, 4,460 citations, and an h-index of 39, providing measurable indicators of publication activity and scholarly visibility.[1] Her ORCID and Google Scholar identifiers provide additional mechanisms for distinguishing and locating her scholarly work.[2][3]

References

  1. Elsevier. (n.d.). Scopus author details: Rose-Mary Boustany, Author ID 7003589401. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7003589401
  2. ORCID. (n.d.). Rose-Mary Boustany — ORCID record.
    https://orcid.org/0000-0002-2066-0079
  3. Google Scholar. (n.d.). Rose-Mary Boustany — Google Scholar profile.
    https://scholar.google.com/citations?user=zFSl2I0AAAAJ&hl=en&oi=sra
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/